Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Molecular PathologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Les acides nucléiques du plasma sanguin chez l'homme [Nuclear Acids In Human Blood Plasma].C R Seances Soc Biol Fil. 1948; 142 (PMID: 18875018): 241-243
- Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.J Clin Invest. 1966; 45 (PMID: 4959277): 1732-1740
- Free DNA in the serum of cancer patients and the effect of therapy.Cancer Res. 1977; 37 (PMID: 837366): 646-650
- Presence of fetal DNA in maternal plasma and serum.Lancet. 1997; 350: 485-487
- The importance of determining the limit of detection of non-invasive prenatal testing methods.Prenat Diagn. 2016; 36 (Epub 2016 Feb 21. PMID: 26815144): 304-311
- Enhanced detection of circulating tumor DNA by fragment size analysis.Sci Transl Med. 2018; 10 (PMID: 30404863): eaat4921
- Detection of circulating tumor DNA in early- and late-stage human malignancies.Sci Transl Med. 2014; 6 (PMID: 24553385): 224ra24
- Assessment of pre-analytical sample handling conditions for comprehensive liquid biopsy analysis.J Mol Diagn. 2020; 22 (Epub 2020 Jun 1. PMID: 32497717): 1070-1086
- Considerations and quality controls when analyzing cell-free tumor DNA.Biomol Detect Quantif. 2019; 17 (PMID: 30906693): 100078
- Evaluation of pre-analytical factors affecting plasma DNA analysis.Sci Rep. 2018; 8: 7375
- Circulating tumoral DNA: preanalytical validation and quality control in a diagnostic laboratory. Circulating tumoral DNA: Preanalytical validation and quality control in a diagnostic laboratory.Anal Biochem. 2018; 542 (Epub 2017 Nov 11. PMID: 29137972): 34-39
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.J Clin Oncol. 2018; 36 (Epub 2018 Mar 5. PMID: 29504847): 1631-1641
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.Nat Med. 2019; 25 (PMID: 31768066): 1928-1937
- Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer.Br J Cancer. 2019; 121 (Epub 2019 Sep 30. PMID: 31564718): 725-737
- Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.Nat Commun. 2017; 8 (PMID: 29109393): 1324
- Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.Science. 2020; 369 (Epub 2020 Apr 28. PMID: 32345712): eabb9601
- Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.J Urol. 2008; 179 (PMID: 18006010): 346-352
- The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review.Cancer Treat Rev. 2018; 66 (Epub 2018 Apr 17. PMID: 29684744): 56-63
- Bladder Cancer (Version 1.2022).https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdfDate accessed: May 3, 2022
- Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.Cancer. 2018; 124 (Epub 2018 Mar 8. PMID: 29517810): 2115-2124
- Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients.EMBO Mol Med. 2018; 10: e9323
- Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.Nature. 2019; 565 (Epub 2019 Jan 23. PMID: 30675060): 654-658
- Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid.J Clin Oncol. 2016; 34 (PMID: 27161972): 2404-2415
- Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord.Proc Natl Acad Sci. 2015; 112 (Epub 2015 Jul 20. PMID: 26195750): 9704-9709
- Breast Cancer (Version 2.2022).https://www.nccn.org/professionals/physician_gls/pdf/breast.pdfDate accessed: May 3, 2022
- Colon Cancer (Version 1.2022).https://www.nccn.org/professionals/physician_gls/pdf/colon.pdfDate accessed: May 3, 2022
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.JAMA Oncol. 2019; 5: 1710-1717
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer.JAMA Oncol. 2019; 5: 1124-1131
- Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences.Clin Cancer Res. 2022; 28 (Epub 2021 Oct 8. PMID: 34625408): 507-517
- ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.Nat Rev Clin Oncol. 2020; 17 (Epub 2020 Jul 6. PMID: 32632268): 757-770
- Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review.Int J Mol Sci. 2018; 19: 3356
- The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer.Clin Colorectal Cancer. 2022; 21 (Online ahead of print. PMID: 35450837): 89-95
- Epi proColon.https://www.epiprocolon.com/us/laboratories/coding-and-reimbursementDate accessed: May 3, 2022
- Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.BMC Cancer. 2020; 20 (PMID: 32024476): 99
- Non-invasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor.Mol Cancer Ther. 2018; 17 (Epub 2018 Aug 10. PMID: 30097488): 2473-2480
- Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors.Ther Adv Med Oncol. 2019; 11 (1758835919831902)
- Detection and localization of surgically resectable cancers with a multianalyte blood test.Science. 2018; 359 (Epub 2018 Jan 18. PMID: 29348365): 926-930
- Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma.Ann Oncol. 2018; 29: 2143
- Exosomes-based detection of EGFR T790M in plasma from non-small cell lung cancer patients.Clin Cancer Res. 2018; 24 (Epub 2018 Mar 13. PMID: 29535126): 2944-2950
- Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia.Sci Adv. 2022; 8 (Epub 2022 Apr 20. PMID: 35442732): eabj1360
Article info
Publication history
Published online: September 28, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
